Biotech

All Articles

Arrowhead fires off stage 3 data in rare metabolic disease in front of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand in front of a prospective face-off with Ionis, publish...

Pfizer, Valneva show lyme disease go reliable for second booster

.Pfizer and also Valneva might have about pair of more years to wait just before they produce the ve...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation along with Ayla Ellison, Strong Biotech Editor-in-Chief and Michelle ...

New data demonstrate how Bayer's asundexian failed to stop movements

.Bayer put on hold the phase 3 trial for its own aspect XIa prevention asundexian late in 2015 after...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own several sclerosis (MS) med tolebrutinib to the FDA, execut...

Galapagos' stock up as fund presents intent to form its development

.Galapagos is actually happening under added stress from clients. Having developed a 9.9% concern in...

Cell- centered Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as well...

Allist pays Jacobio $21M, landing task in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has actually purchased itself a starring job in China's KRAS market...

ReNeuron leaving intention substitution after skipping fundraising goal

.ReNeuron has signed up with the long list of biotechs to leave behind Greater london's goal securit...

MBX declare IPO to take opposition to Ascendis into phase 3

.MBX Biosciences has actually included in the current spurt of IPO filings. The biotech, which filed...